Phibro Animal Health Corporation (NASDAQ:PAHC) CFO Richard G. Johnson sold 55,529 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $36.30, for a total value of $2,015,702.70. Following the completion of the transaction, the chief financial officer now directly owns 15,900 shares in the company, valued at $577,170. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) opened at 35.75 on Monday. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25. The stock has a market capitalization of $1.43 billion, a PE ratio of 22.20 and a beta of 1.36. The stock’s 50 day moving average price is $37.99 and its 200 day moving average price is $33.77.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, beating the consensus estimate of $0.35 by $0.04. Phibro Animal Health Corporation had a return on equity of 47.88% and a net margin of 8.45%. The company had revenue of $194.84 million for the quarter, compared to analyst estimates of $192.47 million. During the same period last year, the company earned $0.32 earnings per share. Phibro Animal Health Corporation’s quarterly revenue was up 3.0% compared to the same quarter last year. Equities research analysts predict that Phibro Animal Health Corporation will post $1.57 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s payout ratio is currently 24.69%.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/09/18/phibro-animal-health-corporation-pahc-cfo-sells-2015702-70-in-stock.html.

PAHC has been the topic of a number of research analyst reports. Piper Jaffray Companies set a $35.00 price target on Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. Bank of America Corporation reissued an “underperform” rating and issued a $33.00 price target on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. BidaskClub cut Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Finally, Credit Suisse Group cut Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and upped their price objective for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Two analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $34.00.

Several large investors have recently modified their holdings of PAHC. Bank of Montreal Can boosted its stake in shares of Phibro Animal Health Corporation by 1,335.9% in the first quarter. Bank of Montreal Can now owns 44,886 shares of the company’s stock worth $1,261,000 after acquiring an additional 41,760 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock worth $211,000 after acquiring an additional 100 shares during the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Phibro Animal Health Corporation in the first quarter worth approximately $748,000. Wells Fargo & Company MN boosted its stake in shares of Phibro Animal Health Corporation by 0.7% in the first quarter. Wells Fargo & Company MN now owns 125,941 shares of the company’s stock worth $3,540,000 after acquiring an additional 932 shares during the last quarter. Finally, Great West Life Assurance Co. Can boosted its stake in shares of Phibro Animal Health Corporation by 7.3% in the first quarter. Great West Life Assurance Co. Can now owns 26,554 shares of the company’s stock worth $745,000 after acquiring an additional 1,802 shares during the last quarter. 48.06% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Stock Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related stocks with our FREE daily email newsletter.